SuperValu Fights New Trial Bid In Whistleblower Drug Case

By Cara Salvatore · April 30, 2025, 9:50 PM EDT

SuperValu urged an Illinois federal judge Tuesday not to overturn its defense win on whistleblower claims of systematic prescription overbilling, saying the whistleblowers are now making "kitchen sink arguments" with little...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

United States of America et al v. Supervalu Inc et al

Case Number

Court

Illinois Central

Nature of Suit

Other Statutory Actions

Date Filed

August 08, 2011

Recent Articles By Cara

April 02, 2025
Yom Kippur Claim Can't Ax $4M Med Mal Award, Panel Says
March 28, 2025
Janssen Owes Additional $1.5B In HIV Prescription Trial
March 17, 2025
Ex-Opioid Co. CEO Wants Out Of Law Firm's Billing Suit
March 05, 2025
SuperValu Wins FCA Case That Went To High Court
February 28, 2025
SuperValu Complains About Falsity Question In FCA Case
February 25, 2025
Wage-Fixing Jury Should Hear Of DOJ Pivot, Exec Says
January 31, 2025
After High Court, SuperValu's $123M FCA Case Heads To Trial
January 23, 2025
Marlboro Smoker Was Target Of Deception, Jury Hears
January 01, 2025
Trials To Watch In 2025
October 31, 2024
Abbott, Mead Cleared In Baby Formula Trial